Soleno Therapeutics Inc (SLNO)
Net Income Growth
148.45%
TTM · Period ending:
SLNO Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported148.45%period ending
Latest reported148.45%period ending
SLNO TTM Net Income YoY % (-274.27% → 148.45%)
Year-over-year change
High-resolution chart · PNG
SLNO net income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Net Income Growth |
|---|---|
| 148.4505% | |
| 111.8794% | |
| 40.1894% | |
| -176.8411% | |
| -280.9821% | |
| -351.0362% | |
| -295.3343% | |
| -129.9167% | |
| -94.8762% | |
| -61.9978% | |
| -54.9722% | |
| -21.4887% | |
| 3.5441% | |
| 22.1385% | |
| 30.7914% | |
| 25.2784% | |
| 0.1983% | |
| -25.4515% | |
| 15.0445% | |
| -16.165% | |
| 6.307% | |
| 19.9357% | |
| -129.2081% | |
| -38.2707% | |
| -72.7071% | |
| -121.9546% | |
| 17.0592% | |
| 3.4273% | |
| -3.6751% | |
| 11.4873% | |
| -44.53% | |
| -65.382% | |
| -40.5434% | |
| -29.8313% | |
| -7.7718% | |
| 4.8548% | |
| -57.9899% | |
| 24.1541% | |
| 41.2169% | |
| 35.8616% | |
| 69.8469% | |
| -14.6459% | |
| -199.0876% | |
| -223.343% | |
| -344.4972% | |
| -274.2737% |